Meet Dr. M S Ramakrishnan, a distinguished leader in the biopharmaceutical industry with expertise in technical product development, as well as in vitro and in vivo pharmacology studies. With over 25 years of experience, Dr. Ramakrishnan has established himself as a subject matter expert in advancing the development pipeline for both novel biologics and biosimilars.
Previously, Dr. Ramakrishnan served as Vice President of Research and Development at Biocon Biologics Limited, where he shaped analytical characterization technologies for both novel and biosimilar monoclonal antibodies, ensuring adherence to the highest standards of product quality to ensure patient safety and efficacy.
With a Ph.D. in Biochemistry from the University of Mysore and post-doctoral research at the esteemed Howard Hughes Medical Institute, University of Chicago, Dr. Ramakrishnan brings a wealth of academic and research expertise to our leadership team. As our Executive Vice President – CDMO, Dr. Ramakrishnan leads with a focus on strengthening our service offerings, meeting global standards, and establishing our company as a prominent CDMO partner in the biopharmaceutical landscape. His strategic vision and commitment to excellence make him an invaluable asset to our organization.
Transforming ideas into impactful solutions is our passion in CDMO services. We're committed to driving excellence and forging partnerships that move the biopharmaceutical industry forward.
Meet Dr. M S Ramakrishnan, a distinguished leader in the biopharmaceutical industry with expertise in technical product development, as well as in vitro and in vivo pharmacology studies. With over 25 years of experience, Dr. Ramakrishnan has established himself as a subject matter expert in advancing the development pipeline for both novel biologics and biosimilars.
Previously, Dr. Ramakrishnan served as Vice President of Research and Development at Biocon Biologics Limited, where he shaped analytical characterization technologies for both novel and biosimilar monoclonal antibodies, ensuring adherence to the highest standards of product quality to ensure patient safety and efficacy.
With a Ph.D. in Biochemistry from the University of Mysore and post-doctoral research at the esteemed Howard Hughes Medical Institute, University of Chicago, Dr. Ramakrishnan brings a wealth of academic and research expertise to our leadership team. As our Executive Vice President – CDMO, Dr. Ramakrishnan leads with a focus on strengthening our service offerings, meeting global standards, and establishing our company as a prominent CDMO partner in the biopharmaceutical landscape. His strategic vision and commitment to excellence make him an invaluable asset to our organization.
Transforming ideas into impactful solutions is our passion in CDMO services. We're committed to driving excellence and forging partnerships that move the biopharmaceutical industry forward.
